Evaluation of the PPAR-γ agonist pioglitazone in mild asthma: a double-blind randomized controlled trial
Background Peroxisome proliferator-activated receptor gamma (PPAR-γ) is a nuclear receptor that modulates inflammation in models of asthma. To determine whether pioglitazone improves measures of asthma control and airway inflammation, we performed a single-center randomized, double-blind, placebo...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Public Library of Science
2016
|
| Online Access: | https://eprints.nottingham.ac.uk/37796/ |